InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（6 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
6
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Janney Daniel, 董事. Officer active across 3 companies, notably Esperion Therapeutics, Inc.. Cumulatively, 9 filings have been recorded. Split: 1 buy · 6 sells. Total volume traded: €17.9m. Activity tracked since 27 May 2021. The latest transaction was disclosed on 27 February 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Janney Daniel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
9,430 股@ US$275.448714.2% 占其流量Common StockSEC:0001711279-26-000023:0
37,895 股@ US$2.460.5% 占其流量Common StockSEC:0001711279-26-000021:0
4,604 股@ US$127.95782.8% 占其流量Common StockSEC:0001711279-23-000046:0
50,000 股@ US$95.023722.6% 占其流量Common StockSEC:0001711279-23-000042:0
17,100 股@ US$90.73567.3% 占其流量Common StockSEC:0001711279-23-000035:0
7,900 股@ US$90.31563.3% 占其流量Common StockSEC:0001711279-23-000023:0
475,000 股@ US$5.02100.0% 占其流量Common StockSEC:0001209191-22-051141:0
标准退出：2022年12月20日 (T+90)
100,000 股@ US$70.5040.2% 占其流量Common StockSEC:0000899243-21-048122:0
12,376 股0Common StockSEC:0001628280-21-011356:0
9 条申报中的 9 条
About Janney Daniel
Daniel Janney serves as a Director at Esperion Therapeutics, Inc. and Krystal Biotech, Inc. In this role, he contributes to the strategy and governance of the companies. His expertise in the biopharmaceutical sector is an asset to the board.
